{"id":"W3087190874","doi":"10.1016/j.jid.2020.06.039","title":"A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans","year":2020,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"Assistance publique-Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris","keywords":"Pazopanib; Dermatofibrosarcoma protuberans; Medicine; Soft tissue sarcoma; Clinical endpoint; Internal medicine; Sarcoma; Oncology; Imatinib; Adverse effect; Dermatofibrosarcoma; PDGFB; Tyrosine-kinase inhibitor; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Surgery; Clinical trial; Pathology; Platelet-derived growth factor receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432091,0.001340169,0.001863285,0.0003285586,0.0003991498,0.000997502,0.0006381965,0.0007847994,0.002744683],"category_scores_gemma":[0.0008435517,0.00056082,0.001627633,0.0004324548,0.0007889076,0.001112214,0.0003200364,0.002595174,0.0006120466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000734387,"about_ca_system_score_gemma":0.00115822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008119572,"about_ca_topic_score_gemma":0.002439896,"domain_scores_codex":[0.9996213,0.0001774176,0.00001690903,0.00007265868,0.00003209597,0.00007969347],"domain_scores_gemma":[0.9994984,0.00009316765,0.00009107975,0.00004594069,0.0000355783,0.0002357975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7549884,0.03615002,0.01873531,0.001439915,0.004896504,0.0006017876,0.0003875013,0.003585189,0.04021305,0.000483854,0.007372037,0.1311463],"study_design_scores_gemma":[0.7426686,0.2217589,0.02553389,0.00005812374,0.001642715,0.0006456783,0.0001484106,0.001304866,0.001898798,0.0003520919,0.003948752,0.00003920637],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907103,0.004102698,0.0005305582,0.0006628479,0.0002228698,0.001182097,0.0009759043,0.00005927965,0.001553336],"genre_scores_gemma":[0.9900035,0.002958629,0.001089065,0.0008786101,0.0001953345,0.001353676,0.0021073,0.00002614052,0.001387685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002744683,"threshold_uncertainty_score":0.009181857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02755172700903237,"score_gpt":0.2859816441672624,"score_spread":0.25842991715823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}